• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重型β地中海贫血患儿在幼儿期存在亚临床出血倾向。

Subclinical haemorrhagic tendency exists in patients with β-thalassaemia major in early childhood.

作者信息

Maiti Abhishek, Chakraborti Amartya, Chakraborty Puranjoy, Mishra Sanjay

机构信息

West Bank Hospital.

出版信息

Australas Med J. 2012;5(2):152-5. doi: 10.4066/AMJ.20121076. Epub 2012 Feb 29.

DOI:10.4066/AMJ.20121076
PMID:22905058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3413934/
Abstract

BACKGROUND

Alterations of coagulation profile have been reported in patients with β-thalassaemia major (β-TM).

METHOD

To investigate this in the paediatric population, we studied haemostatic parameters in pre-transfusion blood samples from 50 non-splenectomised transfusion-dependent children with β-TM (mean age 6±2.5 years) and in blood from 25 healthy controls.

RESULTS

Laboratory evaluation showed thrombocytopenia in 40%, prolongation of prothrombin time (PT) in 12% and prolongation of activated partial thromboplastin time (APTT) in 6% of the patients. Mean values for PT, APTT and platelet count (PC) were all raised in the patient population compared with the controls. The alteration of coagulation status was significant for PT (p value <0.005) and APTT (p value <0.0001). However, the change for PC was not significant (p value <0.05). No significant liner correlation could be identified between PT, APTT, PC of the patients and interval between transfusions (in days) or days since last transfusion.

CONCLUSION

The findings from this study suggest that a subclinical haemorrhagic tendency exists in patients with β-TM at a very early age. The intrinsic pathway appears to be more affected than the extrinsic pathway.

摘要

背景

已有报道称重型β地中海贫血(β-TM)患者的凝血谱发生改变。

方法

为了在儿科人群中对此进行研究,我们对50名未行脾切除术的输血依赖型β-TM儿童(平均年龄6±2.5岁)输血前血样中的止血参数以及25名健康对照者的血液进行了研究。

结果

实验室评估显示,40%的患者存在血小板减少,12%的患者凝血酶原时间(PT)延长,6%的患者活化部分凝血活酶时间(APTT)延长。与对照组相比,患者组的PT、APTT和血小板计数(PC)平均值均升高。凝血状态的改变在PT方面具有显著性(p值<0.005),在APTT方面也具有显著性(p值<0.0001)。然而,PC的变化不具有显著性(p值<0.05)。患者的PT、APTT、PC与输血间隔天数(以天计)或上次输血后的天数之间未发现显著的线性相关性。

结论

本研究结果表明,β-TM患者在很小的年龄就存在亚临床出血倾向。内源性途径似乎比外源性途径受影响更大。

相似文献

1
Subclinical haemorrhagic tendency exists in patients with β-thalassaemia major in early childhood.重型β地中海贫血患儿在幼儿期存在亚临床出血倾向。
Australas Med J. 2012;5(2):152-5. doi: 10.4066/AMJ.20121076. Epub 2012 Feb 29.
2
Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.β-地中海贫血患者的血小板止血特性:输血的影响。
Blood Transfus. 2017 Sep;15(5):413-421. doi: 10.2450/2016.0033-16. Epub 2016 Oct 4.
3
Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.在体外循环后的患者中,通过便携式激光光度计对活化部分凝血活酶时间和凝血酶原时间进行术中测量。
J Cardiothorac Vasc Anesth. 1993 Aug;7(4):402-9. doi: 10.1016/1053-0770(93)90160-m.
4
On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.现场凝血酶原时间、活化部分凝血活酶时间及血小板计数。心脏手术患者全血检测与实验室检测及凝血因子分析的比较。
Anesthesiology. 1994 Feb;80(2):338-51. doi: 10.1097/00000542-199402000-00014.
5
Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction.急性心肌梗死患者凝血酶原时间和活化部分凝血活酶时间的改变
Int J Clin Exp Med. 2013 Apr 12;6(4):294-7. Print 2013.
6
Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.用于测量犬凝血酶原时间、活化部分凝血活酶时间和活化凝血时间的即时检测凝血分析仪的评估。
Am J Vet Res. 2001 Sep;62(9):1455-60. doi: 10.2460/ajvr.2001.62.1455.
7
Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.受伤后国际标准化比值和活化部分凝血活酶时间的变化不能用凝血因子缺乏来解释。
J Trauma Acute Care Surg. 2019 Sep;87(3):582-589. doi: 10.1097/TA.0000000000002385.
8
Coagulation Testing in the Core Laboratory.核心实验室中的凝血检测
Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050.
9
Thalassemia major-- on the verge of bleeding or thrombosis?重型地中海贫血——处于出血或血栓形成的边缘?
Hematology. 2006 Feb;11(1):57-61. doi: 10.1080/10245330500362087.
10
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.

引用本文的文献

1
Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study.重型β地中海贫血患者的天然抗凝蛋白水平:一项病例对照研究。
J Hematol. 2024 Apr;13(1-2):23-28. doi: 10.14740/jh1217. Epub 2024 Apr 9.
2
Bleeding Versus Thrombotic Tendency in Young Children With Beta-Thalassemia Major.重型β地中海贫血幼儿的出血与血栓形成倾向
Cureus. 2021 Dec 6;13(12):e20192. doi: 10.7759/cureus.20192. eCollection 2021 Dec.

本文引用的文献

1
Hematuria in patients with Beta-thalassemia major.
Iran J Kidney Dis. 2010 Apr;4(2):133-6.
2
Thalassemia major-- on the verge of bleeding or thrombosis?重型地中海贫血——处于出血或血栓形成的边缘?
Hematology. 2006 Feb;11(1):57-61. doi: 10.1080/10245330500362087.
3
Coagulation and splenectomy: an overview.凝血与脾切除术:概述
Ann N Y Acad Sci. 2005;1054:317-24. doi: 10.1196/annals.1345.039.
4
Myocardial infarction in a patient with beta-thalassemia major: first report.重型β地中海贫血患者发生心肌梗死:首例报告
Am J Hematol. 2004 Jan;75(1):52-5. doi: 10.1002/ajh.10454.
5
The hypercoagulable state in thalassemia.地中海贫血中的高凝状态。
Blood. 2002 Jan 1;99(1):36-43. doi: 10.1182/blood.v99.1.36.
6
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.中间型地中海贫血脾切除患者的静脉血栓栓塞和高凝状态
Br J Haematol. 2000 Nov;111(2):467-73. doi: 10.1046/j.1365-2141.2000.02376.x.
7
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.重型β地中海贫血患者的慢性高凝状态在儿童期就已存在。
Br J Haematol. 1999 Dec;107(4):739-46. doi: 10.1046/j.1365-2141.1999.01758.x.
8
Thromboembolic events in beta thalassemia major: an Italian multicenter study.重型β地中海贫血中的血栓栓塞事件:一项意大利多中心研究。
Acta Haematol. 1998;99(2):76-9. doi: 10.1159/000040814.
9
Protein C and antithrombin III in polytransfused thalassemic patients.多次输血的地中海贫血患者体内的蛋白C和抗凝血酶III
Acta Haematol. 1987;77(1):30-3. doi: 10.1159/000205945.
10
The spectrum of beta-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis.
Br J Haematol. 1991 Jun;78(2):242-7. doi: 10.1111/j.1365-2141.1991.tb04423.x.